ADI vs ASML

ADI's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. While the company exhibits strong profitability (23.02% net margin, 33.07% operating margin) and impressive revenue and earnings growth (30.4% and 116.7% YoY), its valuation is extremely stretched, trading at a forward P/E of 23.68 and current P/E of 55.85—well above sector averages. The Graham Number ($92.38) and intrinsic value ($161.66) suggest significant upside potential, but the current price of $306.07 reflects a premium driven by high growth expectations, not fundamental undervaluation. Insider selling activity over the past six months (13 transactions, $25.96M in sales) further undermines confidence in near-term prospects.

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.